Alterity Therapeutics
Parkville
About Alterity Therapeutics
Alterity Therapeutics has developed a proprietary library of class-leading chemical compounds. This library is combined with a drug development program to explore novel therapeutics in multiple disease indications. The scientific focus of the company is upon neurological diseases, particularly Alzheimer‘s, Parkinson‘s and Huntington‘s diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $44.6M
- Funding stage: IPO
- Last round: Post-IPO Equity (Sep 2025)
- Ticker: asx:ATH
- Website: alteritytherapeutics.com
- Phone: +61 3 9824 8166
Industries & Categories
Biotechnology, Chemical, Medical
Social Profiles
Canonical: https://fsome.com/organization/alterity-therapeutics-46872 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.